Company intelligence / Profile preview

Medaxis

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Medaxis refers to several distinct entities. One is a wound therapy company with commercially available advanced dynamic wound healing devices/platforms, leveraging proprietary technology with FDA Breakthrough Designation for complex and chronic wounds. Another is a pharmaceutical/nutraceutical company with a commercial portfolio of clinically validated products for chronic disease management and reproductive health. Additionally, a Canadian entity provides pharmaceutical marketing and support services.

Therapeutic areas: EndocrinologyHematologyOtherDermatologyCardiovascularNephrologyWomen's Health
Modalities: DeviceSmall molecule
Industry: Therapeutic Medical Devices

Partnerships

Partnership with Medela to provide NPWT products/services globally using medaxis technology integrated into new standalone company focused on advanced wound care solutions.

Beyond the preview

Go deeper on Medaxis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medaxis.

Explore the full profile